A detailed history of California State Teachers Retirement System transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 47,610 shares of RCUS stock, worth $750,809. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,610
Previous 49,228 3.29%
Holding current value
$750,809
Previous $749,000 2.94%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.69 - $18.01 $22,150 - $29,140
-1,618 Reduced 3.29%
47,610 $727,000
Q2 2024

Aug 14, 2024

BUY
$14.59 - $18.48 $1,035 - $1,312
71 Added 0.14%
49,228 $749,000
Q1 2024

May 15, 2024

SELL
$14.83 - $20.18 $41,983 - $57,129
-2,831 Reduced 5.45%
49,157 $928,000
Q4 2023

Feb 13, 2024

SELL
$13.43 - $19.63 $22,159 - $32,389
-1,650 Reduced 3.08%
51,988 $992,000
Q3 2023

Nov 14, 2023

SELL
$17.62 - $23.54 $43,169 - $57,673
-2,450 Reduced 4.37%
53,638 $962,000
Q2 2023

Aug 21, 2023

SELL
$16.97 - $22.03 $19,888 - $25,819
-1,172 Reduced 2.05%
56,088 $1.14 Million
Q1 2023

May 09, 2023

SELL
$15.96 - $23.15 $13,709 - $19,885
-859 Reduced 1.48%
57,260 $1.04 Million
Q4 2022

Feb 14, 2023

BUY
$19.7 - $35.71 $15,937 - $28,889
809 Added 1.41%
58,119 $1.2 Million
Q3 2022

Nov 18, 2022

SELL
$23.23 - $30.07 $25,831 - $33,437
-1,112 Reduced 1.9%
57,310 $1.5 Million
Q2 2022

Aug 15, 2022

BUY
$17.23 - $37.73 $97,969 - $214,532
5,686 Added 10.78%
58,422 $1.48 Million
Q1 2022

May 16, 2022

SELL
$28.92 - $41.83 $141,187 - $204,214
-4,882 Reduced 8.47%
52,736 $1.66 Million
Q4 2021

Feb 15, 2022

BUY
$31.38 - $48.47 $35,396 - $54,674
1,128 Added 2.0%
57,618 $2.33 Million
Q3 2021

Nov 15, 2021

SELL
$26.93 - $37.68 $159,452 - $223,103
-5,921 Reduced 9.49%
56,490 $1.97 Million
Q2 2021

Aug 16, 2021

SELL
$22.75 - $35.77 $26,139 - $41,099
-1,149 Reduced 1.81%
62,411 $1.71 Million
Q1 2021

May 18, 2021

SELL
$26.16 - $41.39 $6,016 - $9,519
-230 Reduced 0.36%
63,560 $1.79 Million
Q3 2020

Nov 17, 2020

BUY
$17.14 - $25.47 $248,084 - $368,652
14,474 Added 29.35%
63,790 $1.09 Million
Q1 2020

May 13, 2020

SELL
$8.78 - $19.28 $11,159 - $24,504
-1,271 Reduced 2.51%
49,316 $685,000
Q3 2019

Nov 15, 2019

BUY
$6.44 - $10.18 $9,428 - $14,903
1,464 Added 2.98%
50,587 $460,000
Q4 2018

Feb 13, 2019

BUY
$9.74 - $14.5 $341,776 - $508,805
35,090 Added 250.05%
49,123 $529,000
Q3 2018

Nov 14, 2018

BUY
$10.88 - $14.95 $66,640 - $91,568
6,125 Added 77.45%
14,033 $196,000
Q2 2018

Aug 14, 2018

BUY
$12.24 - $17.05 $96,793 - $134,831
7,908 New
7,908 $97,000

Others Institutions Holding RCUS

About Arcus Biosciences, Inc.


  • Ticker RCUS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,160,000
  • Market Cap $1.14B
  • Description
  • Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...
More about RCUS
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.